The TIGeR-PaC clinical trial is a study of Trans-Arterial Micro-Perfusion (TAMP™) for targeted delivery of chemotherapy to disease sites with a FDA cleared medical device system.
Location: United States, California, Los Altos
Employees: 1-10
Phone: +1 650-284-4433
Total raised: $11.15M
Founded date: 2009
Investors 4
| Date | Name | Website |
| - | SV Tech Ve... | svtechvent... |
| - | Astia Ange... | astia.org |
| - | Plug and P... | plugandpla... |
| - | StartX | startx.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 23.05.2018 | - | $10M | - |
| 28.01.2014 | Series B | $1.15M | - |
Mentions in press and media 12
| Date | Title | Description | Source |
| 20.07.2023 | RenovoRx and Imugene Announce plans to Deliver Oncolytic Vir... | Collaboration will explore trans-arterial delivery of Imugene’s CF33 oncolytic virus utilizing Renov... | einpresswi... |
| 20.12.2022 | xCures partners with RenovoRx to assist patients in accessin... | RenovoRx's Phase III clinical study is open to pancreatic adenocarcinoma patients and focuses on ext... | einpresswi... |
| 04.10.2022 | ROTH Capital Partners to Host Inaugural Healthcare Opportuni... | Event to feature company presentations and one-on-one meetings between institutional investors and s... | einpresswi... |
| 16.11.2021 | RenovoRx : Announces Third Quarter 2021 Financial Results - ... | RenovoRx Announces Third Quarter 2021 Financial Results Los Altos, CA, November 15, 2021 - RenovoRx... | marketscre... |
| 07.09.2021 | RenovoRx Receives New 510(k) Clearance for its RenovoCath® D... | LOS ALTOS, Calif., Sept. 7, 2021 /PRNewswire/ -- RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutica... | prnewswire... |
| 25.08.2021 | RenovoRx Announces Pricing of Initial Public Offering | LOS ALTOS, Calif., Aug. 25, 2021 /PRNewswire/ -- RenovoRx, Inc., a biopharmaceutical company and i... | prnewswire... |
| 20.01.2021 | RenovoRx Announces Studies that Further Advance the Science ... | LOS ALTOS, Calif., Jan. 20, 2021 /PRNewswire/ -- RenovoRx, an innovator in targeted cancer therapy... | prnewswire... |
| 23.05.2018 | Boston Scientific Leads $10M Funding for RenovoRx | LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc., a medical technology company developing an innov... | citybizlis... |
| 23.05.2018 | RenovoRx Raises $10M in Financing | RenovoRx, Inc., a Los Altos, Calif.-based medical technology company developing an innovative cathet... | finsmes.co... |
| 23.05.2018 | Term Sheet — Wednesday, May 23 | 5 Qs WITH A DEALMAKER Good morning, Term Sheet readers. Paid Content You can't secure what you can... | fortune.co... |
Show more